导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -28.34% | 1037/1050 |
| 近一周 | -4.04% | 977/1104 |
| 近一月 | -10.34% | 1046/1102 |
| 近一季 | -15.94% | 863/1092 |
| 近半年 | -26.70% | 1046/1070 |
| 近一年 | -29.80% | 985/1018 |
| 近两年 | 0.23% | 885/926 |
| 近三年 | -24.32% | 790/834 |
| 成立以来 | 1.99% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.39% 879/1070 |
-10.12% 914/1101 |
- - |
- - |
| 2025 | 19.26% 682/1065 |
0.40% 767/1014 |
2.48% 468/1038 |
20.96% 580/1050 |
-4.17% 677/1065 |
| 2024 | -4.22% 680/1011 |
-0.07% 319/960 |
-9.01% 828/983 |
10.28% 602/991 |
-4.49% 633/1011 |
| 2023 | -13.23% 445/952 |
6.25% 244/880 |
-6.44% 606/895 |
-7.32% 455/915 |
-5.82% 591/952 |
| 2022 | -22.77% 431/867 |
-20.50% 542/773 |
17.11% 68/806 |
-18.43% 725/845 |
1.68% 341/867 |
| 2021 | -14.51% 512/740 |
-4.58% 324/580 |
6.38% 440/659 |
-18.41% 642/704 |
3.22% 293/740 |
| 2020 | 84.49% 77/554 |
1.04% 133/419 |
27.49% 153/466 |
16.98% 105/517 |
22.43% 94/554 |
| 2019 | 48.20% 162/410 |
28.13% 485/1146 |
4.15% 71/1228 |
4.24% 216/390 |
6.54% 292/410 |
| 2018 | -30.01% 215/349 |
- - |
1.78% 47/990 |
-10.74% 786/1000 |
-12.33% 635/1080 |
| 2017 | -3.81% 185/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.09% 87/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中金消费升级 VS. 东吴新产业精选股票A(580008) |